Skip navigation

News

A patient has just received an injection in their arm

Phase 1 data of mdc-TJK investigational long-acting injectable of olanzapine for schizophrenia patients, exhibited favourable characteristics

26 May 2023

A nurse preps a patient arm for an injection

Phase 3 Study Finds Dupilumab Reduces COPD Exacerbations in Patients With Type 2 Inflammation

26 May 2023

Two people stand back to back lifting their sleeves to show plasters covering their recent injections

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

26 May 2023

A nurse preps a patient arm for an injection

Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)

12 May 2023

A scientist is working in their lab

Anti-HIV injection to be made in South Africa

12 May 2023

A scientist is working in their lab

Valitor Presents Preclinical Data on its Long-acting Anti-VEGF Biologic in Development for Durable Treatment of Wet AMD at the Association for Research in Visio

28 April 2023

A scientist is using a pipette at their workbench

FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long-acting Injectable (LAI)

28 April 2023

A patient has just received an injection in their arm

Skin patches may be more convenient MS antibody medicine

21 April 2023

A syringe is being filled from a vial.

Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use

21 April 2023

Newer stories Older Stories